欧洲社区获得性耐甲氧西林金黄色葡萄球菌
Community acquired MRSA in Europe.
作者信息
Ferry Tristan, Etienne Jerome
出版信息
BMJ. 2007 Nov 10;335(7627):947-8. doi: 10.1136/bmj.39373.465903.BE. Epub 2007 Oct 23.
Abstract
Is less common than in the US but spread must be actively controlled
摘要
虽不如在美国常见，但传播必须得到积极控制
相似文献
1
Community acquired MRSA in Europe.
BMJ. 2007 Nov 10;335(7627):947-8. doi: 10.1136/bmj.39373.465903.BE. Epub 2007 Oct 23.
2
MRSA Has Moved into the Community: a heightened level of concern.
Am J Nurs. 2005 Jul;105(7):20. doi: 10.1097/00000446-200507000-00015.
3
Ciprofloxacin resistanceamong community-derived methicillin-resistant Staphylococcus aureus (MRSA) strains.
Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):779-80.
4
Community-acquired methicillin-resistant Staphylococcus aureus.
JAMA. 1998 Aug 5;280(5):421-2.
5
Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
Semin Pediatr Infect Dis. 2006 Jul;17(3):113-9. doi: 10.1053/j.spid.2006.06.004.
6
CA-MRSA: An old foe develops new fangs.
Mo Med. 2006 Mar-Apr;103(2):129-32.
7
Community acquired methicillin resistant Staphylococcus aureus: A Wisconsin perspective.
WMJ. 2006 Sep;105(6):40-5.
8
Community-acquired methicillin-resistant Staphylococcus aureus infections in a south Indian city.
Southeast Asian J Trop Med Public Health. 2004 Jun;35(2):371-4.
9
CA-MRSA triangulation: virulent strains, susceptible hosts, and contaminated environments.
WMJ. 2006 Sep;105(6):21-3.
10
Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents.
J Hosp Infect. 1997 Dec;37(4):325-9. doi: 10.1016/s0195-6701(97)90149-3.
引用本文的文献
1
Cytotoxicity to cells revealed the virulence-associated protein E gene as a potential virulence factor in methicillin-resistantStaphylococcus aureus.
BMC Microbiol. 2025 Jul 10;25(1):427. doi: 10.1186/s12866-025-04148-4.
2
Clinical Features and Antibiotic Susceptibility of -Infected Dermatoses.
J Clin Med. 2025 Feb 8;14(4):1084. doi: 10.3390/jcm14041084.
3
Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries.
Front Public Health. 2017 Mar 17;5:44. doi: 10.3389/fpubh.2017.00044. eCollection 2017.
4
First autochthonous familial cluster of invasive community-acquired leukocidin-positive methicillin-resistant USA300 Staphylococcus aureus in France.
Folia Microbiol (Praha). 2014 Nov;59(6):473-6. doi: 10.1007/s12223-014-0322-6. Epub 2014 May 24.
5
Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey.
Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1279-84. doi: 10.1007/s10096-011-1441-5. Epub 2011 Oct 14.
6
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
J Antimicrob Chemother. 2011 Nov;66(11):2632-42. doi: 10.1093/jac/dkr344. Epub 2011 Sep 6.
7
The treatment of diabetic foot infections: focus on ertapenem.
Vasc Health Risk Manag. 2009;5:949-63. doi: 10.2147/vhrm.s3162. Epub 2009 Nov 16.
8
Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006.
J Clin Microbiol. 2009 Aug;47(8):2655-7. doi: 10.1128/JCM.00771-09. Epub 2009 Jun 3.
9
Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.
Int J Hematol. 2008 Jun;87(5):516-519. doi: 10.1007/s12185-008-0100-9. Epub 2008 May 21.
10
Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung".
Emerg Radiol. 2009 Mar;16(2):159-62. doi: 10.1007/s10140-008-0706-5. Epub 2008 Feb 15.
本文引用的文献
1
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
JAMA. 2007 Oct 17;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
2
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.
Emerg Infect Dis. 2007 Apr;13(4):594-600. doi: 10.3201/eid1304.061316.
3
Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.
Clin Infect Dis. 2007 Jun 1;44(11):e88-95. doi: 10.1086/517503. Epub 2007 Apr 25.
4
Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
Clin Infect Dis. 2007 Mar 15;44(6):777-84. doi: 10.1086/511872. Epub 2007 Feb 1.
5
Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.
Antimicrob Agents Chemother. 2007 Apr;51(4):1515-9. doi: 10.1128/AAC.01201-06. Epub 2007 Jan 22.
6
Methicillin-resistant S. aureus infections among patients in the emergency department.
N Engl J Med. 2006 Aug 17;355(7):666-74. doi: 10.1056/NEJMoa055356.
7
Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece.
Clin Microbiol Infect. 2006 Jan;12(1):29-34. doi: 10.1111/j.1469-0691.2005.01295.x.
8
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.
Clin Infect Dis. 2006 Mar 1;42(5):647-56. doi: 10.1086/499815. Epub 2006 Jan 25.
9
Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003.
Clin Microbiol Infect. 2005 Jul;11(7):585-7. doi: 10.1111/j.1469-0691.2005.01173.x.
10
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.
N Engl J Med. 2005 Apr 7;352(14):1445-53. doi: 10.1056/NEJMoa042683.
Zotero 插件